Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets.

Hemophilia is classified into mild, moderate, and severe based on coagulation factor activity levels. Factor replacement and prophylaxis regimens in persons with hemophilia have helped to reduce bleeding and its related complications. With several newer treatments, some already approved and others soon to be, there may be a need to consider health-related quality of life in addition to bleed prevention as the goals of providing comprehensive care to persons with hemophilia. In this article, we discussed the reasons why such an approach may be relevant and call for the International Society of Thrombosis and Haemostasis to revisit the current classification of hemophilia. Copyright © 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.

Citation

Jecko Thachil, Jean M Connors, Johnny Mahlangu, Michelle Sholzberg. Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets. Journal of thrombosis and haemostasis : JTH. 2023 Jul;21(7):1737-1740

Mesh Tags

Substances

PMID: 36972786

search → result